The Food and Drug Administration on Monday licensed Merck’s shot designed to give protection to babies from respiration syncytial virus right through their first season of the virus, bringing to marketplace a rival to a an identical remedy from Sanofi and AstraZeneca. The choice will permit the corporate to release …
Read More »